Relief Therapeutics (RLFTF) Stock Price, News & Analysis

Company Overview

Relief Therapeutics is a Swiss biopharmaceutical company focused on developing and commercializing therapies for rare and specialty diseases. The company combines internally developed programs with acquired or partnered products, with an emphasis on treatments intended to address significant unmet medical needs.

Its portfolio has included products and programs in areas such as metabolic disorders, respiratory diseases and other rare conditions. Relief has also been associated with the development of aviptadil, an investigational formulation of vasoactive intestinal peptide, and with GOLIKE, a nutritional product line designed to support the dietary management of phenylketonuria (PKU).

Relief Therapeutics serves international markets through commercial, regulatory and development activities in Europe and other regions. The company is headquartered in Geneva, Switzerland, and has historically pursued growth through collaborations, licensing arrangements and acquisitions of specialty pharmaceutical assets.

Key Stats

• Today's Range: $0.27 to $0.27
• 50-Day Range: $0.24 to $0.32
• 52-Week Range: $0.16 to $4.88
• Volume: N/A
• Average Volume: 3,954 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:RLFTF
• CIK: 1854078
• Web: www.relieftherapeutics.com
• Phone: N/A
• Fax: N/A
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A